Cadralazine
Cadralazine (ISF 2469) is an orally active antihypertensive agent. Cadralazine is a peripheral arteriolar vasodilator[1].
Product Specifications
CAS Number
64241-34-5
Product Name Alternative
ISF 2469
UNSPSC
12352005
Hazard Statement
H302-H315-H319-H335
Target
Drug Derivative
Type
Reference compound
Related Pathways
Others
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/cadralazine.html
Purity
98.74
Solubility
DMSO : 250 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
O=C(NNC1=NN=C(N(CC(C)O)CC)C=C1)OCC
Molecular Formula
C12H21N5O3
Molecular Weight
283.33
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P330-P362+P364-P405-P501
References & Citations
[1]K Takeyama, et al. Antihypertensive activity of cadralazine in experimental hypertensive rats. Arch Int Pharmacodyn Ther. Jan-Feb 1988;291:163-74.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Browse additional items from our catalog
Human X-Box Binding Protein 1 (XBP1) ELISA Kit
Human X-Box Binding Protein 1 (XBP1) ELISA Kit
CD16 (FCGR3A) (NM_000569) Human Over-expression Lysate
